CLYYF: Celyad Oncology SA Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 12.43
Enterprise Value ($M) n/a
Book Value ($M) 0.51
Book Value / Share 0.01
Price / Book n/a
NCAV ($M) -2.90
NCAV / Share -0.07
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -4.11
Return on Assets (ROA) -0.45
Return on Equity (ROE) -1.78

Liquidity (mrq)
Quick Ratio 2.14
Current Ratio 2.29

Balance Sheet (mrq) ($M)
Current Assets 6.51
Assets 9.93
Liabilities 9.42
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.19
Operating Income -5.86
Net Income -5.82

Cash Flow Statement (mra) ($M)
Cash From Operations -5.68
Cash from Investing -0.10
Cash from Financing 2.98

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
CKDXF – Opthea Limited CLCS – Cell Source, Inc.
CLVR – Clever Leaves Holdings Inc. CMRA – Comera Life Sciences Holdings, Inc.
CMVLF – Cellectis S.A.


Financial data and stock pages provided by
Fintel.io